KEY CLINICAL MESSAGE
Angiogenesis Inhibitors (AGI) are not presently used for the treatment of gastric cancers. We show that personalized combination regimens of AGI and cytotoxic anti-cancer agents are a safe, effective and viable treatment strategy in gastric cancers.